FeesSafety
Pluang+

Milestone Pharmaceuticals to present new clinical data on CARDAMYST nasal spray at major cardiology conferences

Market News
19 Oct 2026, 15:00 WIB
GlobeNewsWire
View Source
Bullish
Milestone Pharmaceuticals to present new clinical data on CARDAMYST nasal spray at major cardiology conferences

Milestone Pharmaceuticals announced it will present clinical data and updates on its CARDAMYST (etripamil) nasal spray, approved for treating paroxysmal supraventricular tachycardia (PSVT), at three upcoming cardiology conferences. The presentations will cover safety, efficacy, and ongoing trials, including Phase 3 studies for atrial fibrillation with rapid ventricular rate. CARDAMYST offers a novel, self-administered treatment option for acute PSVT episodes, potentially improving patient management and control. These updates highlight Milestone's progress in expanding the drug's indications and clinical validation.

Milestone Pharmaceuticals clinical data presentations are noted here with Pluang's Health-sector market snapshot as of Oct 19, 2026 18:01 WIB: Among 150 priced Health-sector US stocks tradable on Pluang, 73 rose and 47 fell today. Notable movers include CGC at USD 0.72 with a 1-day change of +1.68%, IONS at USD 43.60 up +1.54%, and ABCL at USD 11.98 rising +1.53%.

More News

Slide Insurance's tech-driven coastal model fuels rapid profit and revenue growth despite hurricane risks.

Slide Insurance's tech-driven coastal model fuels rapid profit and revenue growth despite hurricane risks.

Slide Insurance Holdings, founded in 2021, has rapidly grown by using its Violet data platform to target coastal property insurance markets abandoned by traditional insurers. The company achieved a 38% net profit margin in 2025 and grew revenue from ...

Market News
Bullish
1 hour ago
Top tech investors bet big on AI-driven growth in Salesforce, Microsoft, Meta, and Shopify stocks.

Top tech investors bet big on AI-driven growth in Salesforce, Microsoft, Meta, and Shopify stocks.

Billionaire investor Philippe Laffont significantly increased his holdings in Salesforce, Microsoft, Meta Platforms, and Shopify during Q3, focusing on their strengths in AI technology. Salesforce leads in enterprise AI agents with its Data 360 platf...

Bullish
1 hour ago
Berkshire Hathaway boosts AI-driven stocks like Alphabet, Coca-Cola, and Apple under new CEO Greg Abel.

Berkshire Hathaway boosts AI-driven stocks like Alphabet, Coca-Cola, and Apple under new CEO Greg Abel.

Berkshire Hathaway, led by new CEO Greg Abel, has increased its investments in three major companies—Alphabet, Coca-Cola, and Apple—that are leveraging artificial intelligence to enhance their businesses. These three companies make up 41.6% of Berksh...

Market News
Bullish
1 hour ago
Nike stock falls as competition grows but offers a strong dividend yield near 10-year high.

Nike stock falls as competition grows but offers a strong dividend yield near 10-year high.

Nike's stock has dropped 4.11% amid rising competition from new activewear brands, causing sales to decline for several years. Despite this, Nike remains the largest athletic wear company with $46 billion in revenue, far ahead of Adidas. The company ...

Market News
Bearish
1 hour ago
XRP falls below $1 despite Ripple's rapid growth and new stablecoin RLUSD.

XRP falls below $1 despite Ripple's rapid growth and new stablecoin RLUSD.

XRP has dropped below $1, losing over 55% in a year, even as Ripple, the company behind it, grows rapidly with $900 million in annualized revenue and 1,700+ partners. However, Ripple's stablecoin RLUSD now performs XRP's intended role as a bridge ass...

Market News
Bearish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App